Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
V
van de Donk, Niels
Amsterdam UMC
How do we sequence CART, bispecifics and ADC and other drugs?
Location: Trianti
Niels van de Donk
OA-51: Preliminary Recommendations for Prevention and Management of Infections, Hypogammaglobulinemia, and Neutropenia During Treatment With Teclistamab Based on Experience From the MajesTEC-1 Study
Location: Trianti
Niels van de Donk
van Rhee, Frits
Myeloma Center, University of Arkansas of Medicine
Meet the Professor: Castlemans and POEMS
Location: MC3.3
Frits van Rhee
OA-15: Serial MRD Assessments as a Surrogate for Long Term Progression Free Survival
Location: Mitropoulas
Frits van Rhee
Vanderkerken, Karin
Vrije Universiteit Brusssels
Novel in vivo models of myeloma origin
Location: Trianti
Karin Vanderkerken
Vegivinti, Charan
Jacobi Medical Center / Albert Einstein College of Medicine
OA-31: Efficacy of Bispecific Antibodies in the Treatment of Extramedullary disease and High risk cytogenetics in Relapsed Multiple Myeloma: A Systematic Review
Location: Skalkotas
Charan Vegivinti
Vij, Ravi
Washington University in St. Louis
Special Career Development Session: Round table discussion
Location: Skalkotas
Ravi Vij
